We are live on ! Find out more
ICM

Invenomic Capital Management Portfolio holdings

AUM $1.67B
1-Year Est. Return 1.43%
This Fund
S&P 500
This Quarter Est. Return
-6.53%
1 Year Est. Return
-1.43%
3 Year Est. Return
-6.61%
5 Year Est. Return
-27.23%
10 Year Est. Return
AUM
$2.18B
AUM Growth
+$31.1M
Cap. Flow
+$160M
Cap. Flow %
7.34%
Top 10 Hldgs %
25.32%
Holding
187
New
40
Increased
44
Reduced
62
Closed
37

Top Sells

Rank Stock Value
1
EQX icon
Equinox Gold
EQX
+$42.5M
2
ACHC icon
Acadia Healthcare
ACHC
+$38.6M
3
CNXC icon
Concentrix
CNXC
+$36.4M
4
VTRS icon
Viatris
VTRS
+$33.1M
5
MTB icon
M&T Bank
MTB
+$31.3M

Sector Composition

Rank Sector Weight
1 Technology 30.56%
2 Healthcare 19.11%
3 Consumer Discretionary 12.35%
4 Industrials 11.07%
5 Consumer Staples 7.77%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WT icon
76
WisdomTree
WT
$3.75B
$8.47M 0.39%
581,543
-228,359
-28% -$3.53M
ACH
77
Accendra Health
ACH
$93.8M
$7.68M 0.35%
3,368,975
-133,370
-4% -$307K
ASIX icon
78
AdvanSix
ASIX
$446M
$7.65M 0.35%
313,549
-12,678
-4% -$239K
ROCK icon
79
Gibraltar Industries
ROCK
$1.38B
$7.3M 0.33%
+183,072
New +$8.85M
PRAA icon
80
PRA Group
PRAA
$732M
$7.13M 0.33%
407,398
-19,978
-5% -$304K
PYPL icon
81
PayPal
PYPL
$52.9B
$7M 0.32%
154,819
-249,798
-62% -$12.1M
DMC
82
Del Monte Corp
DMC
$1.49B
$6.93M 0.32%
172,242
-8,420
-5% -$336K
LOVE
83
LoveSac
LOVE
$238M
$6.89M 0.32%
466,748
+104,041
+29% +$1.38M
QTRX icon
84
Quanterix
QTRX
$127M
$6.8M 0.31%
1,932,386
+427,178
+28% +$2.49M
MANH icon
85
Manhattan Associates
MANH
$12.6B
$6.75M 0.31%
+50,679
New +$7.59M
MG icon
86
Mistras Group
MG
$599M
$6.69M 0.31%
452,614
-23,078
-5% -$333K
SPT icon
87
Sprout Social
SPT
$645M
$6.6M 0.3%
1,157,453
+914,341
+376% +$7.04M
UDMY
88
DELISTED
Udemy
UDMY
$6.4M 0.29%
+1,386,098
New +$6.84M
HUBS icon
89
HubSpot
HUBS
$11.8B
$6.4M 0.29%
+26,218
New +$7.35M
PINS icon
90
Pinterest
PINS
$13.2B
$6.29M 0.29%
343,104
-14,755
-4% -$308K
FFWM
91
DELISTED
First Foundation Inc
FFWM
$6.21M 0.28%
1,051,878
-56,578
-5% -$343K
CXT icon
92
Crane NXT
CXT
$2.91B
$6.01M 0.28%
148,181
-6,120
-4% -$297K
MTB icon
93
M&T Bank
MTB
$34.9B
$5.99M 0.27%
28,988
-145,519
-83% -$31.3M
WSBC icon
94
WesBanco
WSBC
$3.88B
$5.95M 0.27%
+172,552
New +$6.02M
WLTH
95
Wealthfront Corp
WLTH
$1.39B
$5.95M 0.27%
+643,328
New +$5.88M
JBSS icon
96
John B. Sanfilippo & Son
JBSS
$886M
$5.86M 0.27%
73,886
-3,588
-5% -$276K
UCB
97
United Community Banks
UCB
$4.25B
$5.65M 0.26%
+179,295
New +$5.9M
SFM icon
98
Sprouts Farmers Market
SFM
$8.1B
$5.41M 0.25%
+70,174
New +$5.24M
ECVT icon
99
Ecovyst
ECVT
$1.12B
$5.38M 0.25%
418,265
-1,488,575
-78% -$16.8M
MLR icon
100
Miller Industries
MLR
$649M
$5.23M 0.24%
114,896
+4,189
+4% +$179K

Similar funds

Invenomic Capital Management's Q1 2026 Portfolio in Review

As of Q1 2026, Invenomic Capital Management held 187 positions worth $2.18B, up 1.4% from $2.15B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Invenomic Capital Management deployed $160M of net new capital in Q1 2026, opening 40 new positions and adding to 44 existing holdings. Its largest new stake was Workday: 559,955 shares worth $72.7M.

By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 21% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was Acadia Healthcare, an estimated $38.6M trimmed.

  • Invenomic Capital Management's largest Q1 2026 buy was Workday: 559,955 shares worth $72.7M.
  • Invenomic Capital Management added most to Fidelity National Information Services in Q1 2026, an estimated $41.7M increase.
  • Invenomic Capital Management's biggest Q1 2026 reduction was Acadia Healthcare, cutting an estimated $38.6M.
  • Invenomic Capital Management fully exited Equinox Gold in Q1 2026, selling an estimated $42.5M.
  • Invenomic Capital Management's ten largest holdings make up 25% of its $2.18B portfolio in Q1 2026.
  • Invenomic Capital Management opened 40 new positions and closed 37 in Q1 2026.
  • Invenomic Capital Management's portfolio value rose 1.4% quarter-over-quarter to $2.18B.

Based on Invenomic Capital Management's 13F filing for Q1 2026, filed 15 May 2026.